The intravenous (IV) ibuprofen market comprises anti-inflammatory drugs that are administered intravenously for the treatment of pain associated with various conditions such as musculoskeletal injury, dental surgery, post-surgical pain management and headaches. IV ibuprofen is preferred over oral medications as it provides faster relief from pain and allows effective administration of medication to patients who have difficulty swallowing tablets or capsules.
The Global Intravenous (IV) Ibuprofen Market is estimated to be valued at US$ 6.91 Bn in 2024 and is expected to exhibit a CAGR of 7.0% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the intravenous (IV) ibuprofen market are Cumberland Pharmaceuticals Inc., Hyloris Pharmaceuticals SA, Grifols, S.A., Recordati Rare Diseases Inc., XGEN PHARMACEUTICALS DJB, Inc., AFT Pharmaceuticals, Laboratorios Valmorca, SGPharma Pvt. Ltd., Wellona Pharma, Delex Pharma, Hikma Pharmaceuticals PLC.
The increasing prevalence of musculoskeletal injuries, chronic pain disorders and postoperative pain is fueling the demand for IV ibuprofen formulation globally. Hospitalization rates have increased in recent years which has augmented the demand for analgesic drugs with fast onset of action and effective pain relief profile.
Major pharmaceutical companies are focusing on expansion in overseas markets to boost sales of IV ibuprofen formulations. Favorable reimbursement coverage for pain management drugs in countries like the U.S. further supports market growth. Pipeline candidates of existing brands are driving research activities to expand indication areas.
Market Key Trends
One of the key trends in the Intravenous (IV) Ibuprofen Market Size is the increase in clinical research for new indications. Pharma companies are conducting phase III/IV trials to evaluate IV ibuprofen efficacy in acute pain conditions like kidney stone pain, postoperative orthopedic pain and cesarean section pain management. This is expected to help gain insurance coverage and expand approved areas of use. Investments into innovative drug delivery systems like soft-gel capsules are also ongoing to enable self-administration and home healthcare of IV medications with less complexity.
Porter’s Analysis
Threat of new entrants: Low economies of scale and established distribution channels create entry barriers. Bargaining power of buyers: Commodity nature of product results in high buyer power. Bargaining power of suppliers: Few suppliers and differentiated products increase supplier power. Threat of new substitutes: New formulations regularly replace older generics, posing substitutes threat. Competitive rivalry: Significant capital requirements and patent expirations intensify competition.
Geographical Regions
North America accounts for the largest share of the intravenous (IV) ibuprofen market currently. The region's advanced healthcare infrastructure, availability of skilled professionals, and growing prevalence of pain disorders are major factors responsible for its large market size.
Asia Pacific is poised to be the fastest growing regional market over the forecast period from 2024 to 2031. This is attributed to rapidly developing economies, increasing healthcare investments, and rising geriatric population afflicted with orthopedic pain related issues in the region. Countries like China and India are main drivers of growth.
Get more insights on This Topic- Intravenous (IV) Ibuprofen Market
Report on World Intravenous (IV) Fluid Bags Market by Product Type, Market, Players and Regions-Forecast to 2025 by DecisionDatabases.comIntravenous (IV) Fluid Bags market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability.The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry Players.Final Report will cover the impact of COVID-19 on this industry.Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/51827-world-intravenous-iv-fluid-bags-market-reportThe Players mentioned in our reportBaxterB.
BraunSIPPEXAmcorSmith MedicalWipakJW Life ScienceFresenius KabiHospira (Pfizer)Global Intravenous (IV) Fluid Bags Market: Product Segment AnalysisPVC MaterialNon- PVC MaterialGlobal Intravenous (IV) Fluid Bags Market: Application Segment AnalysisHome health careHospitalsOther healthcare centersGlobal Intravenous (IV) Fluid Bags Market: Regional Segment AnalysisUSAEuropeJapanChinaIndiaSouth East AsiaDownload Free Sample Report of World Intravenous (IV) Fluid Bags Market @ https://www.decisiondatabases.com/contact/download-sample-51827 There are 10 Chapters to Deeply Display the World Intravenous (IV) Fluid Bags Market.Chapter 1 About the Intravenous (IV) Fluid Bags IndustryChapter 2 World Market Competition LandscapeChapter 3 World Intravenous (IV) Fluid Bags Market shareChapter 4 Supply Chain AnalysisChapter 5 Company ProfilesChapter 6 Globalisation & TradeChapter 7 Distributors and CustomersChapter 8 Import, Export, Consumption and Consumption Value by Major CountriesChapter 9 World Intravenous (IV) Fluid Bags Market Forecast through 2025Chapter 10 Key success factors and Market OverviewPurchase the complete World Intravenous (IV) Fluid Bags Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-51827 Other Reports by DecisionDatabases.com:World Intravenous Immunoglobulin Market Research Report 2025(covering USA, EU, China, South East Asia, Japan and etc)World Oral Fluid Collection Devices Market Research Report 2025 (Covering USA, Europe, China, Japan, India and etc)About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
We provide intellectual, precise and meaningful data at a lightning speed.For more details:DecisionDatabases.comE-Mail: [email protected]: +91 9028057900Web: https://www.decisiondatabases.com/
The latest trending report Global Intravenous (IV) Ibuprofen Market 2020 by Manufacturers Regions Type and Application Forecast to 2025 offered by DecisionDatabases.com is an informative study covering the market with detailed analysis.
The report will assist reader with better understanding and decision making.The global Intravenous (IV) Ibuprofen market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.9% in the forecast period of 2020 to 2025 and will expected to reach USD 10050 million by 2025, from USD 6658.5 million in 2019.The Intravenous (IV) Ibuprofen market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.Final Report will cover the impact of COVID-19 on this industry.Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/40349-intravenous-iv-ibuprofen-industry-analysis-reportThe major players covered in Intravenous (IV) Ibuprofen are:Cumberland PharmaceuticalsGloria PharmaceuticalsSandor MedicaidsAlveda PharmaceuticalsGrifols, CSL LimitedLaboratorios ValmorcaGermin MEDPT.
Soho Industri PharmasiAl Nabeel InternationalBy Type, Intravenous (IV) Ibuprofen market has been segmented into100 mg Dose200 mg Dose400 mg Dose800 mg DoseBy Application, Intravenous (IV) Ibuprofen has been segmented intoPainFeverInflammationThe report offers in-depth assessment of the growth and other aspects of the Intravenous (IV) Ibuprofen market in important countries (regions), includingNorth America (United States, Canada and Mexico)Europe (Germany, France, UK, Russia and Italy)Asia-Pacific (China, Japan, Korea, India and Southeast Asia)South America (Brazil, Argentina, etc.
)Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)Download Free Sample Report of Global Intravenous (IV) Ibuprofen Market @ https://www.decisiondatabases.com/contact/download-sample-40349The content of the study subjects, includes a total of 15 chapters:Chapter 1, to describe Intravenous (IV) Ibuprofen product scope, market overview, market opportunities, market driving force and market risks.Chapter 2, to profile the top manufacturers of Intravenous (IV) Ibuprofen, with price, sales, revenue and global market share of Intravenous (IV) Ibuprofen in 2018 and 2019.Chapter 3, the Intravenous (IV) Ibuprofen competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.Chapter 4, the Intravenous (IV) Ibuprofen breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.Chapter 12, Intravenous (IV) Ibuprofen market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.Chapter 13, 14 and 15, to describe Intravenous (IV) Ibuprofen sales channel, distributors, customers, research findings and conclusion, appendix and data source.Purchase the complete Global Intravenous (IV) Ibuprofen Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-40349Other Reports by DecisionDatabases.com:Global Ibuprofen Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025Global Ketoprofen Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025Global NEOPROFEN Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024About-Us: DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
We provide intellectual, precise and meaningful data at a lightning speed.For more details: DecisionDatabases.com E-Mail: [email protected] Phone: +91 9028057900 Web: https://www.decisiondatabases.com/
Intravenous (IV) Solutions Market: Information by Nutrition Type (Peripheral Parenteral Nutrition and Total Parenteral Nutrition), Bag Type (Large Volume Bags and Small Volume Bags), Nutritional Content (Amino Acid Solution, Carbohydrates, Vitamins & Minerals, Parenteral Lipid Emulsion), End User (Hospitals & clinics, Ambulatory Surgical Centers and Home Care) - Forecast till 2028Market Synopsis:The advancements in the healthcare sector are inducing growth in the markets that offer medical products.
It is expected to witness high demand over the next couple of years.
A study, offered by Market Research Future (MRFR), has found out that the global Intravenous (IV) Solution market is expected to register a CAGR of 7.69% across the projection period 2016 to 2022.
The assessment also asserts that the market is anticipated to scale a valuation of USD 11,511.2 Mn by the end of 2022.IV solutions are extensively used for treatments ranging from fluid deficiency to cancer diagnosis.
The demand for IV solution is huge and signifies opportunities for innovations.
It has already garnered a considerable share of the Intravenous (IV) Solution market and is likely to witness an upswing in demand in the foreseeable future.The healthcare sector is observing a boom and is expected to thrive further over the assessment period.
